Steffen Pietzke, Controller and CAO at PDL BIOPHARMA, INC. (PDLI), bought 20,590 shares at $3.64 ($75K) on 2015-12-07, disclosed to the SEC on 2015-12-07.
Open-market purchase of $75k PDLI by Controller and CAO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| TCDA | BUY | 2018-07-02 | $200K | — | Filing → |